We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Blood Test for Predicting Childhood Diabetes Reconsidered

By LabMedica International staff writers
Posted on 18 Mar 2011
The glycosalated hemoglobin (HbA1c) blood test is a rapid and convenient way of diagnosing diabetes.

The HbA1c test has become the preferred way to diagnose diabetes among the millions of patients who have the disease, but are asymptomatic. More...
The simple test measures longer-term blood sugar levels without requiring patients to fast overnight.

Scientists at the University of Michigan, (Ann Arbor, MI, USA), studied whether the assay could be used to make a diagnosis of diabetes mellitus in adolescents, using the standardized values for adults. For the study, they evaluated the testing results of 1,156 obese and overweight adolescents, aged 12-18 years. The American Diabetes Association, (Alexandria, VA, USA), recommends screening only obese and overweight children because their weight puts them at higher risk for developing diabetes.

Individuals were defined as having diabetes mellitus if their fasting plasma glucose (FPG) was equal to or greater than 126 mg/dL; a 2-hour plasma glucose (2-hr PG) equal to or greater than 200 mg/dL or were prediabetic where the FPG is between 100 and 126 mg/dL; and the 2-hr PG is between 140 and 200 mg/dL. According to the guidelines, individuals without symptoms would be classified as having diabetes if HbA1c values reach 6.5% and as having prediabetes if HbA1c values were between 6.0% and 6.4% on two separate tests.

Only four of the adolescents studied had undiagnosed diabetes mellitus. When assessing FPG to detect diabetes, an HbA1c of 6.5% had sensitivity rates of 75.0% for adolescents and 53.8% adults, although the specificity was higher. Additionally, when assessing FPG to detect diabetes mellitus, an HbA1c of 5.7% had sensitivity rates of 5.0% and 23.1%, and specificity rates of 98.3% and 91.1% for adolescents and adults, respectively. These analyses suggest that HbA1c is a poorer predictor of diabetes mellitus and prediabetes for adolescents compared with adults and performance was poor regardless of whether FPG or 2-hr PG measurements were used.

Joyce M. Lee, MD, MPH, a pediatric endocrinologist, and lead author of the study, said, "We found that hemoglobin A1c is not as reliable a test for identifying children with diabetes and prediabetes compared with adults and using this test in children may lead to missed cases." The study was published online ahead of print on December 30, 2010, in the Journal of Pediatrics.

Related Links:

University of Michigan

American Diabetes Association

Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
HPV Test
Allplex HPV28 Detection
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.